Best Stocks Under $2 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Denison Mines NYSEAMERICAN:DNN$1.38 -0.02 (-1.43%) Closing price 03/14/2025 04:10 PM EasternExtended Trading$1.39 +0.01 (+0.72%) As of 03/14/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MinesMarket Capitalization$1.24 billionP/E Ratio-138.00Consensus RatingStrong BuyConsensus Price Target$3.00 (+117.4% Upside)Volume39.30 million sharesAverage Volume23.90 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Stardust Power NASDAQ:SDST$0.62 +0.02 (+3.49%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$0.60 -0.02 (-3.23%) As of 03/14/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.Market Capitalization$32.73 millionConsensus RatingBuyConsensus Price Target$7.94 (+1,180.2% Upside)Volume305,944 sharesAverage Volume978,168 sharesToday's Range$0.55▼$0.633. enCore Energy NASDAQ:EU$1.45 +0.05 (+3.57%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.45 0.00 (0.00%) As of 03/14/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore EnergyMarket Capitalization$260.77 millionP/E Ratio-5.18Consensus RatingBuyConsensus Price Target$6.50 (+348.3% Upside)Volume1.27 million sharesAverage Volume1.38 million shares4. Quince Therapeutics NASDAQ:QNCX$1.44 +0.03 (+2.13%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.44 0.00 (-0.07%) As of 03/14/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$63.36 millionP/E Ratio-1.16Consensus RatingBuyConsensus Price Target$9.50 (+559.7% Upside)Volume33,787 sharesAverage Volume241,733 shares5. Rezolve AI NASDAQ:RZLV$1.87 +0.23 (+14.02%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.86 -0.01 (-0.75%) As of 03/14/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AIMarket Capitalization$321.98 millionConsensus RatingBuyConsensus Price Target$6.40 (+242.2% Upside)Volume2.93 million sharesAverage Volume5.44 million sharesToday's Range$1.70▼$1.926. GeoVax Labs NASDAQ:GOVX$1.54 0.00 (0.00%) As of 03/14/2025 04:00 PM EasternGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax LabsMarket Capitalization$14.53 millionConsensus RatingBuyConsensus Price Target$14.20 (+822.1% Upside)Volume556,296 sharesAverage Volume658,957 sharesToday's Range$1.50▼$1.62Remove Ads7. Nkarta NASDAQ:NKTX$1.66 -0.06 (-3.49%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.69 +0.03 (+1.81%) As of 03/14/2025 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about NkartaMarket Capitalization$121.38 millionP/E Ratio-0.88Consensus RatingBuyConsensus Price Target$15.00 (+803.6% Upside)Volume1.19 million sharesAverage Volume1.04 million shares8. Cardiol Therapeutics NASDAQ:CRDL$1.13 -0.02 (-1.74%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.07 -0.06 (-5.66%) As of 03/14/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol TherapeuticsMarket Capitalization$93.35 millionP/E Ratio-2.90Consensus RatingBuyConsensus Price Target$8.40 (+643.4% Upside)Volume157,716 sharesAverage Volume390,082 shares9. Reviva Pharmaceuticals NASDAQ:RVPH$1.11 +0.07 (+6.73%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.10 -0.01 (-0.45%) As of 03/14/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$37.12 millionP/E Ratio-1.00Consensus RatingBuyConsensus Price Target$11.40 (+927.0% Upside)Volume765,839 sharesAverage Volume1.07 million shares10. Immunic NASDAQ:IMUX$1.15 +0.03 (+2.68%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.14 -0.01 (-1.30%) As of 03/14/2025 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about ImmunicMarket Capitalization$100.89 millionP/E Ratio-0.93Consensus RatingBuyConsensus Price Target$12.67 (+1,001.4% Upside)Volume534,219 sharesAverage Volume924,680 shares11. Aclaris Therapeutics NASDAQ:ACRS$1.56 0.00 (0.00%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.56 +0.00 (+0.32%) As of 03/14/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris TherapeuticsMarket Capitalization$168.35 millionP/E Ratio-3.00Consensus RatingBuyConsensus Price Target$11.67 (+647.9% Upside)Volume945,317 sharesAverage Volume1.15 million sharesRemove Ads12. Western Copper & Gold NYSE:WRN$1.03 -0.03 (-2.36%) As of 03/14/2025 03:59 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$210.34 millionP/E Ratio-51.75Consensus RatingBuyConsensus Price Target$4.25 (+310.6% Upside)Volume132,861 sharesAverage Volume305,885 shares13. HIVE Digital Technologies NASDAQ:HIVE$1.74 +0.07 (+4.19%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.75 +0.01 (+0.57%) As of 03/14/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital TechnologiesMarket Capitalization$275.08 millionP/E Ratio-34.80Consensus RatingBuyConsensus Price Target$7.64 (+339.2% Upside)Volume5.89 million sharesAverage Volume5.49 million shares14. PMV Pharmaceuticals NASDAQ:PMVP$1.26 +0.02 (+1.61%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.32 +0.06 (+5.08%) As of 03/14/2025 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. More about PMV PharmaceuticalsMarket Capitalization$65.44 millionP/E Ratio-1.26Consensus RatingBuyConsensus Price Target$5.50 (+336.5% Upside)Volume82,407 sharesAverage Volume137,921 shares15. Lucid Diagnostics NASDAQ:LUCD$1.39 +0.11 (+8.59%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.40 +0.01 (+0.72%) As of 03/14/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid DiagnosticsMarket Capitalization$82.49 millionP/E Ratio-1.22Consensus RatingBuyConsensus Price Target$3.63 (+160.8% Upside)Volume1.22 million sharesAverage Volume339,078 shares16. Invivyd NASDAQ:IVVD$0.80 -0.01 (-0.91%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$0.81 +0.01 (+1.03%) As of 03/14/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. More about InvivydMarket Capitalization$96.26 millionP/E Ratio-0.41Consensus RatingBuyConsensus Price Target$7.89 (+880.2% Upside)Volume1.59 million sharesAverage Volume18.70 million sharesRemove Ads17. FibroBiologics NASDAQ:FBLG$1.02 +0.01 (+0.99%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$0.98 -0.04 (-3.92%) As of 03/14/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologicsMarket Capitalization$37.14 millionConsensus RatingBuyConsensus Price Target$13.00 (+1,174.5% Upside)Volume149,191 sharesAverage Volume331,736 sharesToday's Range$1.00▼$1.0518. Rani Therapeutics NASDAQ:RANI$1.51 +0.05 (+3.42%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.54 +0.03 (+1.92%) As of 03/14/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rani Therapeutics Holdings, Inc operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. More about Rani TherapeuticsMarket Capitalization$86.51 millionP/E Ratio-1.42Consensus RatingBuyConsensus Price Target$12.33 (+716.8% Upside)Volume58,235 sharesAverage Volume745,761 shares19. ProQR Therapeutics NASDAQ:PRQR$1.69 -0.05 (-2.87%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.78 +0.10 (+5.62%) As of 03/14/2025 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. More about ProQR TherapeuticsMarket Capitalization$142.12 millionP/E Ratio-5.28Consensus RatingBuyConsensus Price Target$9.50 (+462.1% Upside)Volume614,755 sharesAverage Volume534,193 shares20. Context Therapeutics NASDAQ:CNTX$0.71 +0.05 (+8.02%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$0.73 +0.02 (+3.12%) As of 03/14/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$52.95 millionP/E Ratio-0.78Consensus RatingBuyConsensus Price Target$6.33 (+797.1% Upside)Volume129,899 sharesAverage Volume388,891 shares21. Prime Medicine NYSE:PRME$1.79 +0.07 (+4.07%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.80 +0.01 (+0.84%) As of 03/14/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prime Medicine, Inc, a biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology. More about Prime MedicineMarket Capitalization$234.78 millionP/E Ratio-0.87Consensus RatingBuyConsensus Price Target$13.13 (+633.2% Upside)Volume877,002 sharesAverage Volume1.09 million shares22. Annovis Bio NYSE:ANVS$1.72 +0.08 (+4.55%) Closing price 03/14/2025 03:58 PM EasternExtended Trading$1.74 +0.02 (+1.10%) As of 03/14/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Annovis Bio, Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. More about Annovis BioMarket Capitalization$24.56 millionP/E Ratio-0.39Consensus RatingBuyConsensus Price Target$37.00 (+2,044.9% Upside)Volume173,203 sharesAverage Volume559,353 shares23. Lineage Cell Therapeutics NYSEAMERICAN:LCTX$0.52 0.00 (0.00%) Closing price 03/14/2025 04:10 PM EasternExtended Trading$0.53 +0.01 (+1.35%) As of 03/14/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lineage Cell Therapeutics, Inc, a clinical-stage biotechnology company, develops novel cell therapies for unmet medical needs in the United States and internationally. More about Lineage Cell TherapeuticsMarket Capitalization$114.62 millionP/E Ratio-4.33Consensus RatingBuyConsensus Price Target$4.20 (+707.7% Upside)Volume875,391 sharesAverage Volume1.73 million shares24. ADC Therapeutics NYSE:ADCT$1.84 +0.08 (+4.24%) Closing price 03/14/2025 03:58 PM EasternExtended Trading$1.84 0.00 (0.00%) As of 03/14/2025 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ADC Therapeutics SA focuses on advancing its proprietary antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. More about ADC TherapeuticsMarket Capitalization$178.39 millionP/E Ratio-0.77Consensus RatingBuyConsensus Price Target$8.50 (+360.7% Upside)Volume215,841 sharesAverage Volume476,213 shares25. Vor Biopharma NYSE:VOR$0.90 +0.08 (+9.51%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$0.88 -0.02 (-2.07%) As of 03/14/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vor Biopharma Inc operates as a clinical-stage cell and genome engineering company. Its lead product is tremtelectogene empogeditemcel (trem-cel), an engineered hematopoietic stem cell (eHSC) product candidate that is in phase 1/2 trial to treat acute myeloid leukemia (AML) and other hematological malignancies. More about Vor BiopharmaMarket Capitalization$61.50 millionP/E Ratio-0.54Consensus RatingBuyConsensus Price Target$11.36 (+1,168.2% Upside)Volume271,659 sharesAverage Volume597,505 shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead How Super Micro Computer Stock Is Defying the Market Sell-Off Palantir’s Deal With Archer Aviation Keeps AI’s Future in Focus D-Wave Quantum Stock Jumps on "Quantum Supremacy" News Is a Bottom Finally Forming in Rocket Lab Stock? Intel Stock Surges on New CEO – The Real Story Runs Deeper AMD Stock: Can the PC Refresh Cycle Spark a Rally? Ramaco Resources Pins Hopes on Coal's Untapped Potential Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
